The Prostate

Cover image for The Prostate

1 October 2008

Volume 68, Issue 14

Pages 1487–1598

  1. Rapid Communications

    1. Top of page
    2. Rapid Communications
    3. Original Articles
  2. Original Articles

    1. Top of page
    2. Rapid Communications
    3. Original Articles
    1. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray (pages 1496–1509)

      Mei Jiang, Ming Li, Xuping Fu, Yan Huang, Hui Qian, Ruping Sun, Yumin Mao, Yi Xie and Yao Li

      Version of Record online: 25 MAR 2008 | DOI: 10.1002/pros.20756

    2. Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins (pages 1510–1516)

      Ramneet Kaur, Xin Yuan, Michael L. Lu and Steven P. Balk

      Version of Record online: 18 JUL 2008 | DOI: 10.1002/pros.20787

    3. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy (pages 1517–1530)

      Kerstyn M. Haram, Heidi J. Peltier, Bin Lu, Manoj Bhasin, Hasan H. Otu, Bob Choy, Meredith Regan, Towia A. Libermann, Gary J. Latham, Martin G. Sanda and Mohamed S. Arredouani

      Version of Record online: 30 JUL 2008 | DOI: 10.1002/pros.20803

    4. Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells (pages 1531–1545)

      B. Bindukumar, Stanley Schwartz, Ravikumar Aalinkeel, Supriya Mahajan, Alicia Lieberman and Kailash Chadha

      Version of Record online: 21 JUL 2008 | DOI: 10.1002/pros.20811

    5. Nonhuman primates as models for studies of prostate specific antigen and prostatic diseases (pages 1546–1554)

      James N. Mubiru, Gene B. Hubbard, Edward J. Dick Jr., Jaime Furman, Dean A. Troyer and Jeffrey Rogers

      Version of Record online: 30 JUL 2008 | DOI: 10.1002/pros.20814

    6. Both β-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer (pages 1555–1560)

      Ryutaro Mori, Qingcai Wang, Kathleen D. Danenberg, Jacek K. Pinski and Peter V. Danenberg

      Version of Record online: 23 JUL 2008 | DOI: 10.1002/pros.20815

    7. Disruption of arginase II alters prostate tumor formation in TRAMP mice (pages 1561–1569)

      Shannon M. Mumenthaler, Nora Rozengurt, Justin C. Livesay, Anahita Sabaghian, Stephen D. Cederbaum and Wayne W. Grody

      Version of Record online: 28 JUL 2008 | DOI: 10.1002/pros.20816

    8. Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer (pages 1570–1581)

      Pratap Singh, Gurulingappa Hallur, Ravi K. Anchoori, Oladapo Bakare, Yukio Kageyama, Saeed R. Khan and John T. Isaacs

      Version of Record online: 30 JUL 2008 | DOI: 10.1002/pros.20821

    9. Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era (pages 1582–1591)

      Yen-Ching Chen, John H. Page, Rong Chen and Edward Giovannucci

      Version of Record online: 21 JUL 2008 | DOI: 10.1002/pros.20825

    10. Relationship between serum adiponectin and prostate cancer grade (pages 1592–1598)

      David J. Sher, William K. Oh, Susanna Jacobus, Meredith M. Regan, Gwo-Shu Lee and Christos Mantzoros

      Version of Record online: 21 JUL 2008 | DOI: 10.1002/pros.20823